A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix (Influsplit SSW)2007/2008 in people aged 18 years or above.

Trial Profile

A phase III study for evaluation of immunogenicity and reactogenicity of Fluarix (Influsplit SSW)2007/2008 in people aged 18 years or above.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Nov 2016

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 22 Mar 2012 Primary endpoints identified as reported by European Clinical Trials Database
    • 07 Nov 2011 Actual initiation date (7 May 2007) added as reported by ClinicalTrials.gov.
    • 16 Nov 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top